We are live on ! Find out more
DHFB

Dixon Hubard Feinour & Brown Portfolio holdings

AUM $842M
1-Year Est. Return 2.74%
This Fund
S&P 500
This Quarter Est. Return
+9.49%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
–
AUM
$390M
AUM Growth
$0
Cap. Flow
-$658K
Cap. Flow %
-0.17%
Top 10 Hldgs %
36.69%
Holding
181
New
–
Increased
–
Reduced
3
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$257K
2
NTES icon
NetEase
NTES
+$215K
3
NEE icon
NextEra Energy
NEE
+$186K

Sector Composition

Rank Sector Weight
1 Healthcare 24.4%
2 Technology 24.34%
3 Consumer Discretionary 11.23%
4 Communication Services 8.9%
5 Consumer Staples 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LUNA
176
DELISTED
Luna Innovations Incorporated
LUNA
$60K 0.02%
10,054
– –
TCRT icon
177
Alaunos Therapeutics
TCRT
$4.86M
$50K 0.01%
131
– –
4 5 6 7
8

Similar funds

BDWM
Brewin Dolphin Wealth Management Conskleagh, Dublin, Ireland $917M AUM 12.3% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
TFM
TPI Fund Managers London, United Kingdom $597M AUM 7.13% 1-Year Est. Return
MWM
Minot Wealth Management Westwood, Massachusetts $389M AUM 3.39% 1-Year Est. Return
CP
Corbenic Partners Bethlehem, Pennsylvania $380M AUM 10.47% 1-Year Est. Return
BWM
BT Wealth Management Atlanta, Georgia $356M AUM 9.63% 1-Year Est. Return
FPS
Fieldpoint Private Securities Greenwich, Connecticut $344M AUM 7.21% 1-Year Est. Return
IC
Intersect Capital San Ramon, California $331M AUM 6.79% 1-Year Est. Return

Dixon Hubard Feinour & Brown's Q4 2020 Portfolio in Review

As of Q4 2020, Dixon Hubard Feinour & Brown held 181 positions worth $390M, unchanged from the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Trading was light in Q4 2020: portfolio turnover was 0%. Dixon Hubard Feinour & Brown opened no new positions and made no exits, leaving the 181-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, unchanged from a quarter earlier, followed by Technology and Consumer Discretionary.

  • Dixon Hubard Feinour & Brown's biggest Q4 2020 reduction was Pfizer, cutting an estimated $257K.
  • Dixon Hubard Feinour & Brown's ten largest holdings make up 37% of its $390M portfolio in Q4 2020.
  • Dixon Hubard Feinour & Brown opened 0 new positions and closed 0 in Q4 2020.
  • Dixon Hubard Feinour & Brown's portfolio value was unchanged quarter-over-quarter at $390M.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q4 2020, filed 12 Feb 2021.